Relapse after CAR T and mechanisms of relapse after CAR T
On Friday, September 9, 2022, ASTCT is hosting the second webinar in its 2022 CAR T Webinar Series. Join Drs. Eric Smith and Michael Jain as they review data and strategies to prevent relapse post CAR T, review current CAR T outcomes, and discuss possible published and proposed treatment strategies for CAR T relapse. Dr. Smith's presentation will focus on myeloma, and Dr. Jain's will focus on lymphoma. After their presentations, both speakers will answer questions from the audience.
Dr. Mariana Lucena; Regional Medical Science Director, Medexus Pharma
Dr. Eric Smith; Director of Translational Research (Immune Effector Cell Therapies) at Dana-Farber Cancer Institute and Assistant Professor of Medicine, Harvard Medical School
Dr. Michael Jain; Assistant Member of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center
Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.